Used in research for treating myelofibrosis, a bone marrow disorder. Acts as a JAK1/JAK2 inhibitor, helping reduce spleen enlargement and symptom burden in patients. Also studied for potential in treating other hematologic cancers and inflammatory conditions due to its effect on signaling pathways involved in cell growth and immune response. Investigated in clinical trials for efficacy and safety in chronic inflammatory and proliferative diseases.